Literature DB >> 6099521

Mu-receptor binding in physiological media: comparison with isolated tissue data.

J A Carroll, L Miller, J S Shaw, C P Downes.   

Abstract

Mu-receptor affinities have been determined for a number of opioid drugs using a combination of isolated tissue and receptor binding techniques. The affinities of antagonists and partial agonists were determined by their ability to antagonise responses to [D-Ala2,MePhe4,Glyol5]enkephalin (GLYOL) on the rat vas deferens preparation. There was little correlation between these results and affinities measured by displacement of [3H]-GLYOL from guinea-pig brain membranes incubated in 50mM Tris buffer. By contrast, affinities measured by displacement of [3H]-naloxone from rat brain membranes incubated in a Krebs/HEPES buffer containing a non-hydrolysable analogue of GTP, agreed very closely with the isolated tissue data.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6099521     DOI: 10.1016/0143-4179(84)90034-9

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  5 in total

1.  Differential sensitivity of antinociceptive tests to opioid agonists and partial agonists.

Authors:  J S Shaw; J D Rourke; K M Burns
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

2.  Reversal by beta-funaltrexamine of the antinociceptive effect of opioid agonists in the rat.

Authors:  A G Hayes; M Skingle; M B Tyers
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

3.  The physiological relevance of low agonist affinity binding at opioid mu-receptors.

Authors:  J A Carroll; J S Shaw; A D Wickenden
Journal:  Br J Pharmacol       Date:  1988-06       Impact factor: 8.739

4.  ICI 204448: a kappa-opioid agonist with limited access to the CNS.

Authors:  J S Shaw; J A Carroll; P Alcock; B G Main
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

5.  The contribution of intrinsic activity to the action of opioids in vitro.

Authors:  L Miller; J S Shaw; E M Whiting
Journal:  Br J Pharmacol       Date:  1986-03       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.